102 related articles for article (PubMed ID: 7891931)
1. Cyclosporin in renal transplantation: a 9 year experience.
Yuan ZF; Bailey RR; Gardner J
N Z Med J; 1995 Feb; 108(993):29-32. PubMed ID: 7891931
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppression in live-related donor renal transplantation.
Iman A; Rao M; Juneja R; Jacob CK
Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome after switch from cyclosporine-based triple-drug immunosuppression to double therapy at three months.
Aichberger C; Eberl T; Riedmann B; Pernthaler H; Ofner D; Königsrainer A; Margreiter R
Clin Transplant; 1996 Apr; 10(2):209-12. PubMed ID: 8664521
[TBL] [Abstract][Full Text] [Related]
5. [MMF and CyA in the prevention of early acute rejection after renal transplantation].
He B; Han X; Liu J; Han Z; Guan D; Gao J
Zhonghua Wai Ke Za Zhi; 2000 Sep; 38(9):683-5. PubMed ID: 11832139
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporine trough concentrations in predicting allograft rejection and renal toxicity up to 12 months after renal transplantation.
Min DI; Perry PJ; Chen HY; Hunsicker LG
Pharmacotherapy; 1998; 18(2):282-7. PubMed ID: 9545147
[TBL] [Abstract][Full Text] [Related]
7. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
Bemelman FJ; de Maar EF; Press RR; van Kan HJ; ten Berge IJ; Homan van der Heide JJ; de Fijter HW
Transplantation; 2009 Aug; 88(3):421-8. PubMed ID: 19667948
[TBL] [Abstract][Full Text] [Related]
8. [Safety in the switching traditional cyclosporin to microemulsion cyclosporin in stable renal transplant patients: cooperative study].
Milanés CL; Arminio A; Barrios Y; García-Ramírez R; Herrera J; León I; Salgado O; Terán M; Zschaeck D; Weisinger J
Invest Clin; 1995 Dec; 36(4):183-96. PubMed ID: 8589082
[TBL] [Abstract][Full Text] [Related]
9. Long-term benefits and risks of cyclosporin A (sandimmun)--an analysis at 10 years.
Thiel G; Bock A; Spöndlin M; Brunner FP; Mihatsch M; Rufli T; Landmann J
Transplant Proc; 1994 Oct; 26(5):2493-8. PubMed ID: 7940765
[TBL] [Abstract][Full Text] [Related]
10. Single-center experience with cyclosporine therapy for kidney transplantation: analysis of a twenty-year period in 1200 patients.
Snanoudj R; Kriaa F; Arzouk N; Beaudreuil S; Hiesse C; Durrbach A; Charpentier B
Transplant Proc; 2004 Mar; 36(2 Suppl):83S-88S. PubMed ID: 15041313
[TBL] [Abstract][Full Text] [Related]
11. A case of late onset cyclosporine-induced hemolytic uremic syndrome resulting in renal graft loss.
Katafuchi R; Saito S; Ikeda K; Hirano T; Yanase T; Nakashima K; Fujimi S
Clin Transplant; 1999; 13 Suppl 1():54-8. PubMed ID: 10751058
[TBL] [Abstract][Full Text] [Related]
12. Renal allograft immunosuppression. II. A randomized trial of withdrawal of one drug in triple drug immunosuppression.
Isoniemi H; Ahonen J; Eklund B; Höckerstedt K; Salmela K; von Willebrand E; Häyry P
Transpl Int; 1990 Oct; 3(3):121-7. PubMed ID: 2271083
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic behavior of cyclosporine A in liver dysfunction.
Kihira K; Kadoyama M; Miyake K; Kitaura T; Kimura Y; Yoshida M; Fukuchi H
Hiroshima J Med Sci; 1994 Dec; 43(4):175-8. PubMed ID: 7883584
[TBL] [Abstract][Full Text] [Related]
14. Four-year data after pediatric renal transplantation: a randomized trial of tacrolimus vs. cyclosporin microemulsion.
Filler G; Webb NJ; Milford DV; Watson AR; Gellermann J; Tyden G; Grenda R; Vondrak K; Hughes D; Offner G; Griebel M; Brekke IB; McGraw M; Balzar E; Friman S; Trompeter R
Pediatr Transplant; 2005 Aug; 9(4):498-503. PubMed ID: 16048603
[TBL] [Abstract][Full Text] [Related]
15. Normal renal function 8 to 13 years after cyclosporin A therapy in 285 diabetic patients.
Assan R; Blanchet F; Feutren G; Timsit J; Larger E; Boitard C; Amiel C; Bach JF
Diabetes Metab Res Rev; 2002; 18(6):464-72. PubMed ID: 12469360
[TBL] [Abstract][Full Text] [Related]
16. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
[TBL] [Abstract][Full Text] [Related]
17. Long-term comparative results of C0 and C2 monitoring of CyA in renal transplanted patients.
Paydaş S; Balal M; Sertdemir Y; Seyrek N; Karayaylali I
Ren Fail; 2005; 27(4):409-13. PubMed ID: 16060128
[TBL] [Abstract][Full Text] [Related]
18. Paradoxical cyclosporine A requirements in pediatric renal transplants receiving high-dose steroids.
Hardy KW; Crocker JF; McLellan H; Goralski KB; Renton KW; Acott PD
J Clin Pharmacol; 2005 Feb; 45(2):161-7. PubMed ID: 15647408
[TBL] [Abstract][Full Text] [Related]
19. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
[TBL] [Abstract][Full Text] [Related]
20. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
